FDA Import Refusal 112-8616263-0/2/1 — Glaxo Australia Ply. Ltd.
The FDA refused shipment 112-8616263-0/2/1 from Glaxo Australia Ply. Ltd. (Australia) on Dec 27, 2005. The refused product falls under Drugs and Biologics — ALLOPURINOL SODIUM (ANTI-INFLAMMATORY). Cited charge: 118 This firm has 2 other import refusals on record.
Refusal details
- Date
- Dec 27, 2005
- Country
- Australia
- Product Category
- Drugs and Biologics
- Product Code
- 62GCB86 ALLOPURINOL SODIUM (ANTI-INFLAMMATORY)
- Charges
- 118